Skip to Main content Skip to Navigation
Journal articles

Naphthoquinone–Dopamine Hybrids Inhibit α‐Synuclein Aggregation, Disrupt Preformed Fibrils, and Attenuate Aggregate‐Induced Toxicity

Abstract : Accumulation and aggregation of the intrinsically disordered protein α‐synuclein (α‐Syn) into amyloid fibrils are hallmarks of a series of heterogeneous neurodegenerative disorders, known as synucleinopathies and most notably Parkinson's disease (PD). The crucial role of α‐Syn aggregation in PD makes it an attractive target for the development of disease‐modifying therapeutics that would inhibit α‐Syn aggregation or disrupt its preformed fibrillar assemblies. To this end, we have designed and synthesized two naphthoquinone–dopamine‐based hybrid small molecules, NQDA and Cl‐NQDA, and demonstrated their ability to inhibit in vitro amyloid formation by α‐Syn using ThT assay, CD, TEM, and Congo red birefringence. Moreover, these hybrid molecules efficiently disassembled preformed fibrils of α‐Syn into nontoxic species, as evident from LUV leakage assay. NQDA and Cl‐NQDA were found to have low cytotoxicity and they attenuated the toxicity induced by α‐Syn towards SH‐SY5Y neuroblastoma cells. NQDA was found to efficiently cross an in vitro human blood–brain barrier model. These naphthoquinone–dopamine based derivatives can be an attractive scaffold for therapeutic design towards PD.
Document type :
Journal articles
Complete list of metadata

https://hal-univ-artois.archives-ouvertes.fr/hal-03126960
Contributor : Virginie Justin-Labonne <>
Submitted on : Monday, February 1, 2021 - 11:01:49 AM
Last modification on : Tuesday, February 2, 2021 - 3:25:52 AM

Identifiers

Collections

Citation

Ashim Paul, Adi Huber, Daniel Rand, Fabien Gosselet, Itzik Cooper, et al.. Naphthoquinone–Dopamine Hybrids Inhibit α‐Synuclein Aggregation, Disrupt Preformed Fibrils, and Attenuate Aggregate‐Induced Toxicity. Chemistry - A European Journal, Wiley-VCH Verlag, 2020, 26 (69), pp.16486-16496. ⟨10.1002/chem.202003374⟩. ⟨hal-03126960⟩

Share

Metrics

Record views

32